{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:11:50Z","timestamp":1791839510356,"version":"4.3.4"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10735-026-10775-6","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:14:02Z","timestamp":1773764042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The role of microbiota derived metabolites in modulating diabetic inflammation: a systematic review"],"prefix":"10.1007","volume":"57","author":[{"given":"Venkatesan","family":"Karthick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar","family":"Thamarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Singamoorthy","family":"Amalraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalimuthu","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesan","family":"Manimegalai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"6","key":"10775_CR1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus A, Planchais J, Sokol H (2018) Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23(6):716\u2013724. https:\/\/doi.org\/10.1016\/j.chom.2018.05.003","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10775_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13098-024-01532-w","volume":"17","author":"AR Allam","year":"2025","unstructured":"Allam AR, Helal MB, Alhateem MS et al (2025) Network meta-analysis of randomized control trials evaluating the effectiveness of various probiotic formulations in patients with type 2 diabetes mellitus. Diabetol Metab Syndr 17(1):12. https:\/\/doi.org\/10.1186\/s13098-024-01532-w","journal-title":"Diabetol Metab Syndr"},{"issue":"12","key":"10775_CR3","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3390\/nu10121971","volume":"10","author":"L Barrea","year":"2018","unstructured":"Barrea L, Annunziata G, Muscogiuri G et al (2018) Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome. Nutrients 10(12):1971. https:\/\/doi.org\/10.3390\/nu10121971","journal-title":"Nutrients"},{"key":"10775_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/ITT.S499605","volume":"14","author":"A Berbudi","year":"2025","unstructured":"Berbudi A, Khairani S, Tjahjadi AI (2025) Interplay between insulin resistance and immune dysregulation in type 2 diabetes mellitus: implications for therapeutic interventions. ImmunoTargets Ther 14:359\u2013382. https:\/\/doi.org\/10.2147\/ITT.S499605","journal-title":"ImmunoTargets Ther"},{"issue":"6","key":"10775_CR5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00125-017-4278-3","volume":"60","author":"L Brunkwall","year":"2017","unstructured":"Brunkwall L, Orho-Melander M (2017) The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities. Diabetologia 60(6):997\u20131005. https:\/\/doi.org\/10.1007\/s00125-017-4278-3","journal-title":"Diabetologia"},{"issue":"6","key":"10775_CR6","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2337\/dci24-0052","volume":"47","author":"M Byndloss","year":"2024","unstructured":"Byndloss M, Devkota S, Duca F et al (2024) The gut microbiota and diabetes: research, translation, and clinical applications\u20142023 diabetes, diabetes care, and diabetologia expert forum. Diabetes Care 47(6):947\u2013957. https:\/\/doi.org\/10.2337\/dci24-0052","journal-title":"Diabetes Care"},{"issue":"7","key":"10775_CR7","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani PD, Amar J, Iglesias MA et al (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56(7):1761\u20131772. https:\/\/doi.org\/10.2337\/db06-1491","journal-title":"Diabetes"},{"issue":"11","key":"10775_CR8","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.3390\/diagnostics12112783","volume":"12","author":"M Canyelles","year":"2022","unstructured":"Canyelles M, P\u00e9rez A, Junza A et al (2022) Divergent effects of glycemic control and bariatric surgery on circulating concentrations of TMAO in newly diagnosed T2D patients and morbidly obese. Diagnostics 12(11):2783. https:\/\/doi.org\/10.3390\/diagnostics12112783","journal-title":"Diagnostics"},{"issue":"3","key":"10775_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/nu5030829","volume":"5","author":"AM Caricilli","year":"2013","unstructured":"Caricilli AM, Saad MJA (2013) The role of gut microbiota on insulin resistance. Nutrients 5(3):829\u2013851. https:\/\/doi.org\/10.3390\/nu5030829","journal-title":"Nutrients"},{"issue":"6","key":"10775_CR10","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1073\/pnas.1322269111","volume":"111","author":"PV Chang","year":"2014","unstructured":"Chang PV, Hao L, Offermanns S, Medzhitov R (2014) The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A 111(6):2247\u20132252. https:\/\/doi.org\/10.1073\/pnas.1322269111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10775_CR11","doi-asserted-by":"publisher","first-page":"1282699","DOI":"10.3389\/fendo.2023.1282699","volume":"14","author":"T Chen","year":"2024","unstructured":"Chen T, Wang J, Liu Z, Gao F (2024) Effect of supplementation with probiotics or synbiotics on cardiovascular risk factors in patients with metabolic syndrome: a systematic review and meta-analysis of randomized clinical trials. Front Endocrinol (Lausanne) 14:1282699. https:\/\/doi.org\/10.3389\/fendo.2023.1282699","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"10775_CR12","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.3390\/nu14091977","volume":"14","author":"J Cong","year":"2022","unstructured":"Cong J, Zhou P, Zhang R (2022) Intestinal microbiota-derived short chain fatty acids in host health and disease. Nutrients 14(9):1977. https:\/\/doi.org\/10.3390\/nu14091977","journal-title":"Nutrients"},{"issue":"4","key":"10775_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1055\/s-0035-1569330","volume":"124","author":"M Dambrova","year":"2016","unstructured":"Dambrova M, Latkovskis G, Kuka J et al (2016) Diabetes is associated with higher trimethylamine n-oxide plasma levels. Exp Clin Endocrinol Diabetes 124(4):251\u2013256. https:\/\/doi.org\/10.1055\/s-0035-1569330","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"10775_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/gutjnl-2013-306423","volume":"64","author":"V De Preter","year":"2015","unstructured":"De Preter V, Machiels K, Joossens M et al (2015) Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut 64(3):447\u2013458. https:\/\/doi.org\/10.1136\/gutjnl-2013-306423","journal-title":"Gut"},{"key":"10775_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.607475","volume":"12","author":"LN Ding","year":"2021","unstructured":"Ding LN, Ding WY, Ning J et al (2021) Effects of probiotic supplementation on inflammatory markers and glucose homeostasis in adults with type 2 diabetes mellitus: a systematic review and meta-analysis. Front Pharmacol 12:607475. https:\/\/doi.org\/10.3389\/fphar.2021.607475","journal-title":"Front Pharmacol"},{"issue":"2","key":"10775_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2019-001040","volume":"6","author":"JJ Dinicolantonio","year":"2019","unstructured":"Dinicolantonio JJ, McCarty M, Okeefe J (2019) Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: Is TMAO serving as a marker for hepatic insulin resistance. Open Heart 6(2):e001040. https:\/\/doi.org\/10.1136\/openhrt-2019-001040","journal-title":"Open Heart"},{"issue":"7682","key":"10775_CR17","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature24661","volume":"551","author":"D Dodd","year":"2017","unstructured":"Dodd D, Spitzer MH, Van Treuren W et al (2017) A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 551(7682):648\u2013652. https:\/\/doi.org\/10.1038\/nature24661","journal-title":"Nature"},{"issue":"22","key":"10775_CR18","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","volume":"110","author":"A Everard","year":"2013","unstructured":"Everard A, Belzer C, Geurts L et al (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 110(22):9066\u20139071. https:\/\/doi.org\/10.1073\/pnas.1219451110","journal-title":"Proc Natl Acad Sci USA"},{"key":"10775_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114344","volume":"160","author":"W Feng","year":"2023","unstructured":"Feng W, Yang Z, Liu Y et al (2023) Gut microbiota: A new target of traditional Chinese medicine for insomnia. Biomed Pharmacother 160:114344. https:\/\/doi.org\/10.1016\/j.biopha.2023.114344","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10775_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/ph18010045","volume":"18","author":"S Fiorucci","year":"2025","unstructured":"Fiorucci S, Urbani G, Distrutti E, Biagioli M (2025) Obeticholic acid and other farnesoid-X-resor (FXR) agonists in the treatment of liver disorders. Pharmaceuticals 18(1):45. https:\/\/doi.org\/10.3390\/ph18010045","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10775_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-025-01834-y","volume":"25","author":"N Ganamurali","year":"2026","unstructured":"Ganamurali N, Sabarathinam S (2026a) Bidirectional interplay between the gut microbiota and GLP-1 receptor agonists: towards microbiome-mediated therapeutics in type 2 diabetes mellitus. J Diabetes Metab Disord 25(1):44. https:\/\/doi.org\/10.1007\/s40200-025-01834-y","journal-title":"J Diabetes Metab Disord"},{"key":"10775_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.70001","volume":"15","author":"N Ganamurali","year":"2026","unstructured":"Ganamurali N, Sabarathinam S (2026b) The triple-agonist revolution: retatrutide and the paradigm shift in multi-hormonal pharmacotherapy for obesity and cardiometabolic comorbidities. Clin Pharmacol Drug Dev 15:e70001. https:\/\/doi.org\/10.1002\/cpdd.70001","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"7","key":"10775_CR23","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/db08-1637","volume":"58","author":"Z Gao","year":"2009","unstructured":"Gao Z, Yin J, Zhang J et al (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58(7):1509\u20131517. https:\/\/doi.org\/10.2337\/db08-1637","journal-title":"Diabetes"},{"issue":"1","key":"10775_CR24","first-page":"15","volume":"10","author":"D Ghafouri","year":"2025","unstructured":"Ghafouri D (2025) The effects of probiotics, prebiotics and synbiotics on glycemic control in diabetic patients: a narrative and meta-analysis study. Int J Nutr Sci 10(1):15\u201328","journal-title":"Int J Nutr Sci"},{"issue":"12","key":"10775_CR25","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.2337\/dc08-1341","volume":"31","author":"JS Gonzalez","year":"2008","unstructured":"Gonzalez JS, Peyrot M, McCarl LA et al (2008) Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 31(12):2398\u20132403. https:\/\/doi.org\/10.2337\/dc08-1341","journal-title":"Diabetes Care"},{"issue":"16","key":"10775_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168870","volume":"22","author":"C G\u00fcnther","year":"2021","unstructured":"G\u00fcnther C, Rothhammer V, Karow M et al (2021) The gut-brain axis in inflammatory bowel disease\u2014current and future perspectives. Int J Mol Sci 22(16):8870. https:\/\/doi.org\/10.3390\/ijms22168870","journal-title":"Int J Mol Sci"},{"key":"10775_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/srep20602","volume":"6","author":"Z Guo","year":"2016","unstructured":"Guo Z, Zhang J, Wang Z et al (2016) Intestinal microbiota distinguish gout patients from healthy humans. Sci Rep 6:20602. https:\/\/doi.org\/10.1038\/srep20602","journal-title":"Sci Rep"},{"key":"10775_CR28","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.2147\/JIR.S470254","volume":"17","author":"M Guo","year":"2024","unstructured":"Guo M, Wu Y, Peng M et al (2024) Decreasing of trimethylamine N-oxide by Cecal microbiota and choline-trimethylamine Lyase are associated with Sishen pill on diarrhea with kidney-yang deficiency syndrome. J Inflamm Res 17:7275\u20137294. https:\/\/doi.org\/10.2147\/JIR.S470254","journal-title":"J Inflamm Res"},{"key":"10775_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.clnesp.2024.11.011","volume":"65","author":"A Habibi","year":"2025","unstructured":"Habibi A, Letafatkar N, Sattari N et al (2025) Modulation of inflammatory markers in type 2 diabetes mellitus through gut microbiome-targeted interventions: an umbrella review on meta-analyses. Clin Nutr ESPEN 65:93\u2013104. https:\/\/doi.org\/10.1016\/j.clnesp.2024.11.011","journal-title":"Clin Nutr ESPEN"},{"issue":"5","key":"10775_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00592-020-01652-z","volume":"58","author":"SY Han","year":"2021","unstructured":"Han SY, Song HK, Cha JJ et al (2021) Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model. Acta Diabetol 58(5):623\u2013636. https:\/\/doi.org\/10.1007\/s00592-020-01652-z","journal-title":"Acta Diabetol"},{"issue":"1","key":"10775_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2232143","volume":"15","author":"B Han","year":"2023","unstructured":"Han B, Lv X, Liu G et al (2023) Gut microbiota-related bile acid metabolism-FXR\/TGR5 axis impacts the response to anti-\u03b14\u03b27-integrin therapy in humanized mice with colitis. Gut Microbes 15(1):2232143. https:\/\/doi.org\/10.1080\/19490976.2023.2232143","journal-title":"Gut Microbes"},{"issue":"1","key":"10775_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jhep.2021.01.047","volume":"75","author":"SA Harrison","year":"2021","unstructured":"Harrison SA, Bashir MR, Lee KJ et al (2021) A structurally optimized FXR agonist, MET409, reduced liver fat content over 12 weeks in patients with non-alcoholic steatohepatitis. J Hepatol 75(1):25\u201333. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.047","journal-title":"J Hepatol"},{"issue":"7","key":"10775_CR33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004951","volume":"6","author":"Y Heianza","year":"2017","unstructured":"Heianza Y, Ma W, Manson JAE et al (2017) Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies. J Am Heart Assoc 6(7):e004951. https:\/\/doi.org\/10.1161\/JAHA.116.004951","journal-title":"J Am Heart Assoc"},{"key":"10775_CR34","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114525105709","author":"L Hong","year":"2025","unstructured":"Hong L, Zheng Y, Yang W et al (2025) Effects of probiotic supplementation on intestinal microbiota in patients with diabetes\/prediabetes: a systematic review and meta-analysis of randomized controlled trials. Br J Nutr. https:\/\/doi.org\/10.1017\/S0007114525105709","journal-title":"Br J Nutr"},{"issue":"7","key":"10775_CR35","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","volume":"24","author":"L Hoyles","year":"2018","unstructured":"Hoyles L, Fern\u00e1ndez-Real JM, Federici M et al (2018) Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nat Med 24(7):1070\u20131080. https:\/\/doi.org\/10.1038\/s41591-018-0061-3","journal-title":"Nat Med"},{"issue":"11","key":"10775_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23115905","volume":"23","author":"J Hu","year":"2022","unstructured":"Hu J, Zheng P, Qiu J et al (2022) High-amylose corn starch regulated gut microbiota and serum bile acids in high-fat diet-induced obese mice. Int J Mol Sci 23(11):5905. https:\/\/doi.org\/10.3390\/ijms23115905","journal-title":"Int J Mol Sci"},{"key":"10775_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.634780","volume":"11","author":"X Jia","year":"2021","unstructured":"Jia X, Xu W, Zhang L et al (2021) Impact of gut microbiota and microbiota-related metabolites on hyperlipidemia. Front Cell Infect Microbiol 11:634780. https:\/\/doi.org\/10.3389\/fcimb.2021.634780","journal-title":"Front Cell Infect Microbiol"},{"key":"10775_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138496","volume":"287","author":"V Karthick","year":"2025","unstructured":"Karthick V, Zahir AA, Amalraj S et al (2025) Sustained release of nano-encapsulated glimepiride drug with chitosan nanoparticles: a novel approach to control type 2 diabetes in streptozotocin-induced Wistar albino rats. Int J Biol Macromol 287:138496. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138496","journal-title":"Int J Biol Macromol"},{"issue":"10","key":"10775_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/nu10101499","volume":"10","author":"KEB Knudsen","year":"2018","unstructured":"Knudsen KEB, L\u00e6rke HN, Hedemann MS et al (2018) Impact of diet-modulated butyrate production on intestinal barrier function and inflammation. Nutrients 10(10):1499. https:\/\/doi.org\/10.3390\/nu10101499","journal-title":"Nutrients"},{"issue":"6","key":"10775_CR40","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F (2016) From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165(6):1332\u20131345. https:\/\/doi.org\/10.1016\/j.cell.2016.05.041","journal-title":"Cell"},{"issue":"3","key":"10775_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031222","volume":"23","author":"P Konopelski","year":"2022","unstructured":"Konopelski P, Mogilnicka I (2022) Biological effects of Indole-3-Propionic Acid, a gut microbiota-derived metabolite, and its precursor Tryptophan in mammals\u2019 health and disease. Int J Mol Sci 23(3):1222. https:\/\/doi.org\/10.3390\/ijms23031222","journal-title":"Int J Mol Sci"},{"issue":"13","key":"10775_CR42","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1016\/j.celrep.2019.02.090","volume":"26","author":"P Kovatcheva-Datchary","year":"2019","unstructured":"Kovatcheva-Datchary P, Shoaie S, Lee S et al (2019) Simplified intestinal microbiota to study microbe-diet-host interactions in a mouse model. Cell Rep 26(13):3772\u20133783. https:\/\/doi.org\/10.1016\/j.celrep.2019.02.090","journal-title":"Cell Rep"},{"key":"10775_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1161353","volume":"10","author":"Y Lei","year":"2023","unstructured":"Lei Y, Xu M, Huang N, Yuan Z (2023) Meta-analysis of the effect of probiotics or synbiotics on the risk factors in patients with coronary artery disease. Front Cardiovasc Med 10:1161353. https:\/\/doi.org\/10.3389\/fcvm.2023.1161353","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"10775_CR44","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.22844","volume":"4","author":"RN Lemaitre","year":"2021","unstructured":"Lemaitre RN, Jensen PN, Wang Z et al (2021) Association of trimethylamine N-oxide and related metabolites in plasma and incident type 2 diabetes: the cardiovascular health study. JAMA Netw Open 4(9):e2122844. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.22844","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10775_CR45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.gtc.2023.11.001","volume":"53","author":"Y Li","year":"2024","unstructured":"Li Y, Han S (2024) Metabolomic applications in gut microbiota-host interactions in human diseases. Gastroenterol Clin North Am 53(1):153\u2013169. https:\/\/doi.org\/10.1016\/j.gtc.2023.11.001","journal-title":"Gastroenterol Clin North Am"},{"issue":"24","key":"10775_CR46","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1161\/CIRCULATIONAHA.115.019645","volume":"133","author":"J Li","year":"2016","unstructured":"Li J, Lin S, Vanhoutte PM et al (2016) Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe-\/- mice. Circulation 133(24):2434\u20132446. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.019645","journal-title":"Circulation"},{"key":"10775_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.852718","volume":"12","author":"R Li","year":"2022","unstructured":"Li R, Wang X, Zhang Y et al (2022) Analysis of Tryptophan and its main metabolite Kynurenine and the risk of multiple cancers based on the bidirectional Mendelian Randomization Analysis. Front Oncol 12:852718. https:\/\/doi.org\/10.3389\/fonc.2022.852718","journal-title":"Front Oncol"},{"issue":"1","key":"10775_CR48","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12967-023-04084-2","volume":"21","author":"G Li","year":"2023","unstructured":"Li G, Feng H, Mao XL et al (2023) The effects of probiotics supplementation on glycaemic control among adults with type 2 diabetes mellitus: a systematic review and meta-analysis of randomised clinical trials. J Transl Med 21(1):241. https:\/\/doi.org\/10.1186\/s12967-023-04084-2","journal-title":"J Transl Med"},{"issue":"5","key":"10775_CR49","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00394-020-02431-w","volume":"60","author":"W Liu","year":"2021","unstructured":"Liu W, Luo X, Tang J et al (2021) A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier. Eur J Nutr 60(5):2317\u20132330. https:\/\/doi.org\/10.1007\/s00394-020-02431-w","journal-title":"Eur J Nutr"},{"issue":"7","key":"10775_CR50","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00125-022-05713-6","volume":"65","author":"J Liu","year":"2022","unstructured":"Liu J, Bai R, Chai Z et al (2022) Low- and middle-income countries demonstrate rapid growth of Type 2 Diabetes: an analysis based on Global Burden of Disease 1990\u20132019 data. Diabetologia 65(7):1139\u20131152. https:\/\/doi.org\/10.1007\/s00125-022-05713-6","journal-title":"Diabetologia"},{"issue":"6","key":"10775_CR51","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.cmet.2024.04.019","volume":"36","author":"JL Liu","year":"2024","unstructured":"Liu JL, Xu X, Rixiati Y et al (2024) Dysfunctional circadian clock accelerates cancer metastasis by intestinal microbiota triggering accumulation of myeloid-derived suppressor cells. Cell Metab 36(6):1184\u20131201. https:\/\/doi.org\/10.1016\/j.cmet.2024.04.019","journal-title":"Cell Metab"},{"issue":"2","key":"10775_CR52","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.numecd.2024.11.015","volume":"35","author":"X Liu","year":"2025","unstructured":"Liu X, Tong Y, Qin J, Zhao Y (2025) Efficacy and safety of probiotic and synbiotic supplementation in metabolic syndrome: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis 35(2):245\u2013258. https:\/\/doi.org\/10.1016\/j.numecd.2024.11.015","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"10775_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01743-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh JS, Mak WQ, Tan LKS et al (2024) Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther 9(1):37. https:\/\/doi.org\/10.1038\/s41392-024-01743-1","journal-title":"Signal Transduct Target Ther"},{"key":"10775_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2024.112521","volume":"136","author":"D Ma","year":"2025","unstructured":"Ma D, Zhao P, Gao J et al (2025a) Probiotic supplementation contributes to glycemic control in adults with type 2 diabetes: a systematic review and network meta-analysis. Nutrition 136:112521. https:\/\/doi.org\/10.1016\/j.nut.2024.112521","journal-title":"Nutrition"},{"issue":"1","key":"10775_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-025-95813-1","volume":"15","author":"S Ma","year":"2025","unstructured":"Ma S, Sun Q, Xu Y et al (2025b) Identification of risk factors for diabetes in Chinese middle-aged and elderly adults. Sci Rep 15(1):1\u201314. https:\/\/doi.org\/10.1038\/s41598-025-95813-1","journal-title":"Sci Rep"},{"key":"10775_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-025-10452-2","author":"AN Mafe","year":"2025","unstructured":"Mafe AN, Edo GI, Akpoghelie PO et al (2025) Probiotics and food bioactives: unraveling their impact on gut microbiome, inflammation, and metabolic health. Probiotics Antimicrob Proteins. https:\/\/doi.org\/10.1007\/s12602-025-10452-2","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"9","key":"10775_CR57","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01021-z","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann ER, Lam YK, Uhlig HH (2024) Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol 24(9):577\u2013595. https:\/\/doi.org\/10.1038\/s41577-024-01021-z","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10775_CR58","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.copbio.2010.03.020","volume":"21","author":"TM Marques","year":"2010","unstructured":"Marques TM, Wall R, Ross RP et al (2010) Programming infant gut microbiota: influence of dietary and environmental factors. Curr Opin Biotechnol 21(2):149\u2013156. https:\/\/doi.org\/10.1016\/j.copbio.2010.03.020","journal-title":"Curr Opin Biotechnol"},{"issue":"7268","key":"10775_CR59","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","volume":"461","author":"KM Maslowski","year":"2009","unstructured":"Maslowski KM, Vieira AT, Ng A et al (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461(7268):1282\u20131286. https:\/\/doi.org\/10.1038\/nature08530","journal-title":"Nature"},{"issue":"7","key":"10775_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068626","volume":"8","author":"G Mattace Raso","year":"2013","unstructured":"Mattace Raso G, Simeoli R, Russo R et al (2013) Effects of Sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet. PLoS ONE 8(7):e68626. https:\/\/doi.org\/10.1371\/journal.pone.0068626","journal-title":"PLoS ONE"},{"issue":"3","key":"10775_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26031094","volume":"26","author":"E M\u0142ynarska","year":"2025","unstructured":"M\u0142ynarska E, Czarnik W, Dzie\u017ca N et al (2025) Type 2 Diabetes Mellitus: new pathogenetic mechanisms, treatment and the most important complications. Int J Mol Sci 26(3):1094. https:\/\/doi.org\/10.3390\/ijms26031094","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10775_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/nu15071642","volume":"15","author":"J Mu","year":"2023","unstructured":"Mu J, Guo X, Zhou Y, Cao G (2023) The effects of probiotics\/synbiotics on glucose and lipid metabolism in women with Gestational Diabetes Mellitus: a meta-analysis of randomized controlled trials. Nutrients 15(7):1642. https:\/\/doi.org\/10.3390\/nu15071642","journal-title":"Nutrients"},{"issue":"1","key":"10775_CR63","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3164\/jcbn.20-101","volume":"67","author":"Y Naito","year":"2020","unstructured":"Naito Y, Ushiroda C, Mizushima K et al (2020) Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids. J Clin Biochem Nutr 67(1):19\u201324. https:\/\/doi.org\/10.3164\/jcbn.20-101","journal-title":"J Clin Biochem Nutr"},{"issue":"10","key":"10775_CR64","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.3329\/bjms.v25i10.86638","volume":"25","author":"SM Nandini","year":"2026","unstructured":"Nandini SM, K L, T S, Ramalingam S (2026) Gut microbiota dysbiosis and its correlation with viral load in chronic hepatitis B patients from Chennai, Tamil Nadu. Bangladesh J Med Sci 25(10):S154\u2013S158. https:\/\/doi.org\/10.3329\/bjms.v25i10.86638","journal-title":"Bangladesh J Med Sci"},{"issue":"3","key":"10775_CR65","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4183\/aeb.2018.287","volume":"14","author":"Y Naraoka","year":"2018","unstructured":"Naraoka Y, Yamaguchi T, Hu A et al (2018) Short chain fatty acids upregulate adipokine production in Type 2 Diabetes-derived human adipocytes. Acta Endocrinol (Copenh) 14(3):287\u2013293. https:\/\/doi.org\/10.4183\/aeb.2018.287","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"5","key":"10775_CR66","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s00394-023-03140-w","volume":"62","author":"K Naseri","year":"2023","unstructured":"Naseri K, Saadati S, Ghaemi F et al (2023) The effects of probiotic and synbiotic supplementation on inflammation, oxidative stress, and circulating adiponectin and leptin concentration in subjects with prediabetes and type 2 diabetes mellitus: a GRADE-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials. Eur J Nutr 62(5):2043\u20132061. https:\/\/doi.org\/10.1007\/s00394-023-03140-w","journal-title":"Eur J Nutr"},{"issue":"1","key":"10775_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05249-7","volume":"9","author":"JM Natividad","year":"2018","unstructured":"Natividad JM, Lamas B, Pham HP et al (2018) Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice. Nat Commun 9(1):2806. https:\/\/doi.org\/10.1038\/s41467-018-05249-7","journal-title":"Nat Commun"},{"issue":"1","key":"10775_CR68","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.73452","volume":"17","author":"OM Odeniran","year":"2025","unstructured":"Odeniran OM (2025) Exploring the potential of Bambara Groundnut flour as an alternative for diabetic and obese patients in the USA: a comprehensive review. Cureus 17(1):e73452. https:\/\/doi.org\/10.7759\/cureus.73452","journal-title":"Cureus"},{"issue":"15","key":"10775_CR69","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.3390\/nu15153472","volume":"15","author":"S Paquette","year":"2023","unstructured":"Paquette S, Thomas SC, Venkataraman K et al (2023) The effects of oral probiotics on type 2 diabetes mellitus (T2DM): a clinical trial systematic literature review. Nutrients 15(15):3472. https:\/\/doi.org\/10.3390\/nu15153472","journal-title":"Nutrients"},{"issue":"7611","key":"10775_CR70","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nature18646","volume":"535","author":"HK Pedersen","year":"2016","unstructured":"Pedersen HK, Gudmundsdottir V, Nielsen HB et al (2016) Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535(7611):273\u2013281. https:\/\/doi.org\/10.1038\/nature18646","journal-title":"Nature"},{"issue":"9","key":"10775_CR71","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","volume":"139","author":"L Peng","year":"2009","unstructured":"Peng L, Li ZR, Green RS et al (2009) Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 139(9):1619\u20131625. https:\/\/doi.org\/10.3945\/jn.109.104638","journal-title":"J Nutr"},{"issue":"10","key":"10775_CR72","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1111\/j.1464-5491.2005.01644.x","volume":"22","author":"M Peyrot","year":"2005","unstructured":"Peyrot M, Rubin RR, Lauritzen T et al (2005) Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med 22(10):1379\u20131385. https:\/\/doi.org\/10.1111\/j.1464-5491.2005.01644.x","journal-title":"Diabet Med"},{"issue":"2","key":"10775_CR73","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/dom.12811","volume":"19","author":"A Pingitore","year":"2017","unstructured":"Pingitore A, Chambers ES, Hill T et al (2017) The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro. Diabetes Obes Metab 19(2):257\u2013265. https:\/\/doi.org\/10.1111\/dom.12811","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10775_CR74","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/dom.13529","volume":"21","author":"A Pingitore","year":"2019","unstructured":"Pingitore A, Gonzalez-Abuin N, Ruz-Maldonado I et al (2019) Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: role of free fatty acid receptor 2. Diabetes Obes Metab 21(3):481\u2013487. https:\/\/doi.org\/10.1111\/dom.13529","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10775_CR75","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nm.4236","volume":"23","author":"H Plovier","year":"2017","unstructured":"Plovier H, Everard A, Druart C et al (2017) A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med 23(1):107\u2013113. https:\/\/doi.org\/10.1038\/nm.4236","journal-title":"Nat Med"},{"issue":"6","key":"10775_CR76","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jhep.2010.12.030","volume":"54","author":"TWH Pols","year":"2011","unstructured":"Pols TWH, Noriega LG, Nomura M et al (2011) The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol 54(6):1263\u20131272. https:\/\/doi.org\/10.1016\/j.jhep.2010.12.030","journal-title":"J Hepatol"},{"key":"10775_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118014","volume":"186","author":"A Rahimi","year":"2025","unstructured":"Rahimi A, Baghernejadan Z, Hazrati A et al (2025) Combination therapy with immune checkpoint inhibitors in colorectal cancer: challenges, resistance mechanisms, and the role of microbiota. Biomed Pharmacother 186:118014. https:\/\/doi.org\/10.1016\/j.biopha.2025.118014","journal-title":"Biomed Pharmacother"},{"key":"10775_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/srep26745","volume":"6","author":"E Randrianarisoa","year":"2016","unstructured":"Randrianarisoa E, Lehn-Stefan A, Wang X et al (2016) Relationship of serum trimethylamine N-oxide (TMAO) levels with early atherosclerosis in humans. Sci Rep 6:26745. https:\/\/doi.org\/10.1038\/srep26745","journal-title":"Sci Rep"},{"issue":"2","key":"10775_CR79","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","volume":"47","author":"JM Ridlon","year":"2006","unstructured":"Ridlon JM, Kang DJ, Hylemon PB (2006) Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47(2):241\u2013259. https:\/\/doi.org\/10.1194\/jlr.R500013-JLR200","journal-title":"J Lipid Res"},{"issue":"4","key":"10775_CR80","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cmet.2020.03.003","volume":"31","author":"EC Rosser","year":"2020","unstructured":"Rosser EC, Piper CJM, Matei DE et al (2020) Microbiota-derived metabolites suppress arthritis by amplifying Aryl-Hydrocarbon Receptor activation in regulatory B cells. Cell Metab 31(4):837\u2013851. https:\/\/doi.org\/10.1016\/j.cmet.2020.03.003","journal-title":"Cell Metab"},{"issue":"11","key":"10775_CR81","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00592-022-01934-8","volume":"59","author":"D Salamone","year":"2022","unstructured":"Salamone D, Costabile G, Corrado A et al (2022) Circulating short-chain fatty acids in type 2 diabetic patients and overweight\/obese individuals. Acta Diabetol 59(11):1483\u20131491. https:\/\/doi.org\/10.1007\/s00592-022-01934-8","journal-title":"Acta Diabetol"},{"issue":"2","key":"10775_CR82","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.001","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin SI, Wahlstr\u00f6m A, Felin J et al (2013) Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17(2):225\u2013235. https:\/\/doi.org\/10.1016\/j.cmet.2013.01.001","journal-title":"Cell Metab"},{"issue":"1","key":"10775_CR83","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41392-024-01746-y","volume":"9","author":"D Semo","year":"2024","unstructured":"Semo D, Reinecke H, Godfrey R (2024) Gut microbiome regulates inflammation and insulin resistance: a novel therapeutic target to improve insulin sensitivity. Signal Transduct Target Ther 9(1):117. https:\/\/doi.org\/10.1038\/s41392-024-01746-y","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10775_CR84","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/cphy.c130023","volume":"4","author":"MA Serrat","year":"2014","unstructured":"Serrat MA (2014) Environmental temperature impact on bone and cartilage growth. Compr Physiol 4(2):621\u2013655. https:\/\/doi.org\/10.1002\/cphy.c130023","journal-title":"Compr Physiol"},{"key":"10775_CR85","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-024-10368-z","author":"A Setayesh","year":"2025","unstructured":"Setayesh A, Karimi M, Karimi MA et al (2025a) Effects of probiotic and synbiotic supplementation on glycemic indices in adult individuals with prediabetes and Type 2 Diabetes Mellitus: a grade-assessed systematic review and dose-response meta-analysis of RCTs. Probiotics Antimicrob Proteins. https:\/\/doi.org\/10.1007\/s12602-024-10368-z","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"1","key":"10775_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.advnut.2024.100342","volume":"16","author":"A Setayesh","year":"2025","unstructured":"Setayesh A, Karimi M, Valizadeh F et al (2025b) Probiotics and synbiotics supplementation reduce inflammatory cytokines in individuals with prediabetes and type 2 diabetes mellitus: findings from a systematic review meta-analysis. Adv Nutr 16(1):100342. https:\/\/doi.org\/10.1016\/j.advnut.2024.100342","journal-title":"Adv Nutr"},{"key":"10775_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2025.100419","volume":"28","author":"N Shalbaf","year":"2025","unstructured":"Shalbaf N, Sadeghi S, Homaee S, Saberian F (2025) Probiotics, prebiotics, synbiotics, and FMT for glycemic control: a systematic review of clinical efficacy and mechanistic readouts in Type 2 diabetes and related dysglycemia. Metabol Open 28:100419. https:\/\/doi.org\/10.1016\/j.metop.2025.100419","journal-title":"Metabol Open"},{"key":"10775_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.762580","volume":"13","author":"J Shen","year":"2022","unstructured":"Shen J, Yang L, You K et al (2022) Indole-3-Acetic Acid alters intestinal microbiota and alleviates Ankylosing Spondylitis in mice. Front Immunol 13:762580. https:\/\/doi.org\/10.3389\/fimmu.2022.762580","journal-title":"Front Immunol"},{"issue":"1","key":"10775_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-023-01338-x","volume":"23","author":"S Soltani","year":"2023","unstructured":"Soltani S, Ashoori M, Dehghani F et al (2023) Effects of probiotic\/synbiotic supplementation on body weight in patients with diabetes: a systematic review and meta-analyses of randomized-controlled trials. BMC Endocr Disord 23(1):104. https:\/\/doi.org\/10.1186\/s12902-023-01338-x","journal-title":"BMC Endocr Disord"},{"key":"10775_CR90","doi-asserted-by":"publisher","first-page":"1245678","DOI":"10.3389\/fmed.2025.1245678","volume":"12","author":"G Song","year":"2025","unstructured":"Song G, Xie Y, Yi L et al (2025) Bile acids affect intestinal barrier function through FXR and TGR5. Front Med (Lausanne) 12:1245678. https:\/\/doi.org\/10.3389\/fmed.2025.1245678","journal-title":"Front Med (Lausanne)"},{"issue":"29","key":"10775_CR91","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/eurheartj\/ehu207","volume":"35","author":"EW Steyerberg","year":"2014","unstructured":"Steyerberg EW, Vergouwe Y (2014) Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J 35(29):1925\u20131931. https:\/\/doi.org\/10.1093\/eurheartj\/ehu207","journal-title":"Eur Heart J"},{"issue":"3","key":"10775_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoggr.2024.100378","volume":"4","author":"AV Suastika","year":"2024","unstructured":"Suastika AV, Widiana IGR, Fatmawati NND et al (2024) The role of probiotics and synbiotics on treatment of gestational diabetes: systematic review and meta-analysis. AJOG Glob Rep 4(3):100378. https:\/\/doi.org\/10.1016\/j.ajoggr.2024.100378","journal-title":"AJOG Glob Rep"},{"issue":"12","key":"10775_CR93","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","volume":"24","author":"L Sun","year":"2018","unstructured":"Sun L, Xie C, Wang G et al (2018) Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat Med 24(12):1919\u20131929. https:\/\/doi.org\/10.1038\/s41591-018-0222-4","journal-title":"Nat Med"},{"issue":"2","key":"10775_CR94","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s44197-023-00138-9","volume":"13","author":"J Sun","year":"2023","unstructured":"Sun J, Hu W, Ye S et al (2023) The description and prediction of incidence, prevalence, mortality, disability-adjusted life years cases, and corresponding age-standardized rates for global diabetes. J Epidemiol Glob Health 13(2):331\u2013343. https:\/\/doi.org\/10.1007\/s44197-023-00138-9","journal-title":"J Epidemiol Glob Health"},{"issue":"3","key":"10775_CR95","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","volume":"116","author":"WHW Tang","year":"2014","unstructured":"Tang WHW, Wang Z, Kennedy DJ et al (2014) Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res 116(3):448\u2013455. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.305360","journal-title":"Circ Res"},{"issue":"1","key":"10775_CR96","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1373\/clinchem.2016.263640","volume":"63","author":"WHW Tang","year":"2017","unstructured":"Tang WHW, Wang Z, Li XS et al (2017) Increased trimethylamine N-oxide portends high mortality risk independent of glycemic control in patients with type 2 diabetes mellitus. Clin Chem 63(1):257\u2013264. https:\/\/doi.org\/10.1373\/clinchem.2016.263640","journal-title":"Clin Chem"},{"issue":"2","key":"10775_CR97","doi-asserted-by":"publisher","first-page":"450","DOI":"10.26599\/FSHW.2024.9250002","volume":"14","author":"Y Tian","year":"2025","unstructured":"Tian Y, Xia J, Li L et al (2025) Effects of probiotics, prebiotics and synbiotics supplementation on cardiovascular risk factors in patients with type 2 diabetes mellitus: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. Food Sci Hum Wellness 14(2):450\u2013468. https:\/\/doi.org\/10.26599\/FSHW.2024.9250002","journal-title":"Food Sci Hum Wellness"},{"issue":"7","key":"10775_CR98","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/nu15071712","volume":"15","author":"HJ Tsai","year":"2023","unstructured":"Tsai HJ, Hung WC, Hung WW et al (2023) Circulating short-chain fatty acids and non-alcoholic fatty liver disease severity in patients with type 2 diabetes mellitus. Nutrients 15(7):1712. https:\/\/doi.org\/10.3390\/nu15071712","journal-title":"Nutrients"},{"issue":"2","key":"10775_CR99","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.immuni.2014.06.014","volume":"41","author":"M Venkatesh","year":"2014","unstructured":"Venkatesh M, Mukherjee S, Wang H et al (2014) Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and toll-like receptor 4. Immunity 41(2):296\u2013310. https:\/\/doi.org\/10.1016\/j.immuni.2014.06.014","journal-title":"Immunity"},{"key":"10775_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.703218","volume":"9","author":"A Visekruna","year":"2021","unstructured":"Visekruna A, Luu M (2021) The role of short-chain fatty acids and bile acids in intestinal and liver function, inflammation, and carcinogenesis. Front Cell Dev Biol 9:703218. https:\/\/doi.org\/10.3389\/fcell.2021.703218","journal-title":"Front Cell Dev Biol"},{"key":"10775_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2013.12.015","volume":"38","author":"Y Wang","year":"2014","unstructured":"Wang Y, Kasper LH (2014) The role of microbiome in central nervous system disorders. Brain Behav Immun 38:1\u201312. https:\/\/doi.org\/10.1016\/j.bbi.2013.12.015","journal-title":"Brain Behav Immun"},{"issue":"7418","key":"10775_CR102","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Wang","year":"2012","unstructured":"Wang J, Qin J, Li Y et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490(7418):55\u201360. https:\/\/doi.org\/10.1038\/nature11450","journal-title":"Nature"},{"issue":"7","key":"10775_CR103","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","volume":"163","author":"Z Wang","year":"2015","unstructured":"Wang Z, Roberts AB, Buffa JA et al (2015) Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163(7):1585\u20131595. https:\/\/doi.org\/10.1016\/j.cell.2015.11.055","journal-title":"Cell"},{"issue":"1","key":"10775_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41401-025-01693-6","volume":"47","author":"RX Wang","year":"2026","unstructured":"Wang RX, Afzal A, Jing XY et al (2026) Intergenerational effects of the microbiota on neurodevelopment: Mechanisms and therapeutic perspectives. Acta Pharmacol Sin 47(1):1\u201323. https:\/\/doi.org\/10.1038\/s41401-025-01693-6","journal-title":"Acta Pharmacol Sin"},{"key":"10775_CR105","volume-title":"World Health Organization Diabetes","author":"WHO","year":"2023","unstructured":"WHO (2023) World Health Organization Diabetes. World Health Organization, Geneva"},{"issue":"5","key":"10775_CR106","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s13238-020-00814-7","volume":"12","author":"J Wu","year":"2021","unstructured":"Wu J, Wang K, Wang X et al (2021) The role of the gut microbiome and its metabolites in metabolic diseases. Protein Cell 12(5):360\u2013373. https:\/\/doi.org\/10.1007\/s13238-020-00814-7","journal-title":"Protein Cell"},{"issue":"4","key":"10775_CR107","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3390\/nu15040830","volume":"15","author":"R Xiao","year":"2023","unstructured":"Xiao R, Wang L, Tian P et al (2023) The effect of probiotic supplementation on glucolipid metabolism in patients with type 2 diabetes: a systematic review and meta-analysis. Nutrients 15(4):830. https:\/\/doi.org\/10.3390\/nu15040830","journal-title":"Nutrients"},{"issue":"2","key":"10775_CR108","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/87559129.2024.2345678","volume":"41","author":"MX Xie","year":"2025","unstructured":"Xie MX, Ye JL, Chen HQ et al (2025) Effects and mechanisms of probiotics, prebiotics, synbiotics and postbiotics for the prevention and management of type 2 diabetes mellitus. Food Rev Int 41(2):145\u2013168. https:\/\/doi.org\/10.1080\/87559129.2024.2345678","journal-title":"Food Rev Int"},{"issue":"8","key":"10775_CR109","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1007\/s00018-021-03762-x","volume":"78","author":"W Xu","year":"2021","unstructured":"Xu W, Ocak U, Gao L et al (2021) Selective autophagy as a therapeutic target for neurological diseases. Cell Mol Life Sci 78(8):3835\u20133852. https:\/\/doi.org\/10.1007\/s00018-021-03762-x","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"10775_CR110","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1080\/10408398.2022.2135402","volume":"64","author":"D Xu","year":"2024","unstructured":"Xu D, Fu L, Pan D et al (2024) Role of probiotics\/synbiotic supplementation in glycemic control: a critical umbrella review of meta-analyses of randomized controlled trials. Crit Rev Food Sci Nutr 64(12):3812\u20133824. https:\/\/doi.org\/10.1080\/10408398.2022.2135402","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"8","key":"10775_CR111","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","volume":"35","author":"C Xue","year":"2023","unstructured":"Xue C, Li G, Zheng Q et al (2023) Tryptophan metabolism in health and disease. Cell Metab 35(8):1304\u20131326. https:\/\/doi.org\/10.1016\/j.cmet.2023.06.004","journal-title":"Cell Metab"},{"key":"10775_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00724","volume":"11","author":"J Yang","year":"2020","unstructured":"Yang J, Wise L, Fukuchi KI (2020) TLR4 cross-talk with NLRP3 inflammasome and complement signaling pathways in Alzheimer\u2019s Disease. Front Immunol 11:724. https:\/\/doi.org\/10.3389\/fimmu.2020.00724","journal-title":"Front Immunol"},{"issue":"1","key":"10775_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04236-y","volume":"21","author":"F Zeinali","year":"2020","unstructured":"Zeinali F, Aghaei Zarch SM, Vahidi Mehrjardi MY et al (2020) Effects of synbiotic supplementation on gut microbiome, serum level of TNF-\u03b1, and expression of microRNA-126 and microRNA-146a in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomized clinical trial. Trials 21(1):285. https:\/\/doi.org\/10.1186\/s13063-020-04236-y","journal-title":"Trials"},{"issue":"2","key":"10775_CR114","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante T, Iannitti RG, Cunha C et al (2013) Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39(2):372\u2013385. https:\/\/doi.org\/10.1016\/j.immuni.2013.08.003","journal-title":"Immunity"},{"issue":"13","key":"10775_CR115","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnz153","volume":"366","author":"S Zhai","year":"2019","unstructured":"Zhai S, Qin S, Li L et al (2019) Dietary butyrate suppresses inflammation through modulating gut microbiota in high-fat diet-fed mice. FEMS Microbiol Lett 366(13):fnz153. https:\/\/doi.org\/10.1093\/femsle\/fnz153","journal-title":"FEMS Microbiol Lett"},{"issue":"12","key":"10775_CR116","doi-asserted-by":"publisher","first-page":"5471","DOI":"10.1111\/1750-3841.15951","volume":"86","author":"Z Zhai","year":"2021","unstructured":"Zhai Z, Niu KM, Liu H et al (2021) Policosanol alleviates hepatic lipid accumulation by regulating bile acids metabolism in C57BL6\/mice through AMPK\u2013FXR\u2013TGR5 cross-talk. J Food Sci 86(12):5471\u20135484. https:\/\/doi.org\/10.1111\/1750-3841.15951","journal-title":"J Food Sci"},{"issue":"1","key":"10775_CR117","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.febslet.2007.11.010","volume":"582","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Edwards PA (2008) FXR signaling in metabolic disease. FEBS Lett 582(1):10\u201318. https:\/\/doi.org\/10.1016\/j.febslet.2007.11.010","journal-title":"FEBS Lett"},{"key":"10775_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s40104-016-0139-z","volume":"8","author":"S Zhang","year":"2017","unstructured":"Zhang S, Zeng X, Ren M et al (2017) Novel metabolic and physiological functions of branched chain amino acids: a review. J Anim Sci Biotechnol 8:10. https:\/\/doi.org\/10.1186\/s40104-016-0139-z","journal-title":"J Anim Sci Biotechnol"},{"key":"10775_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108418","volume":"169","author":"L Zhao","year":"2020","unstructured":"Zhao L, Lou H, Peng Y et al (2020) Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota. Diabetes Res Clin Pract 169:108418. https:\/\/doi.org\/10.1016\/j.diabres.2020.108418","journal-title":"Diabetes Res Clin Pract"},{"key":"10775_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118182","volume":"188","author":"M Zhao","year":"2025","unstructured":"Zhao M, Zhao J, Yang H et al (2025) The bile acid-gut microbiota axis: a central hub for physiological regulation and a novel therapeutic target for metabolic diseases. Biomed Pharmacother 188:118182. https:\/\/doi.org\/10.1016\/j.biopha.2025.118182","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10775_CR121","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","volume":"33","author":"X Zheng","year":"2021","unstructured":"Zheng X, Chen T, Jiang R et al (2021) Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab 33(4):791\u2013803. https:\/\/doi.org\/10.1016\/j.cmet.2020.11.017","journal-title":"Cell Metab"},{"issue":"1","key":"10775_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-025-01218-1","volume":"24","author":"K Zhuang","year":"2025","unstructured":"Zhuang K, Luo H, Zeng M et al (2025) Effects of probiotics, prebiotics, and synbiotics on gut microbiota in older adults: a systematic review and meta-analysis of randomized controlled trials. Nutr J 24(1):5. https:\/\/doi.org\/10.1186\/s12937-025-01218-1","journal-title":"Nutr J"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10775-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10775-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10775-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:57:32Z","timestamp":1777366652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-026-10775-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":122,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10775"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10775-6","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"113"}}